Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 12.00 million. The enterprise value is 8.35 million.
Market Cap | 12.00M |
Enterprise Value | 8.35M |
Important Dates
The last earnings date was Wednesday, August 20, 2025.
Earnings Date | Aug 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding.
Current Share Class | 10.44M |
Shares Outstanding | 10.44M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 26.27% |
Owned by Institutions (%) | 0.62% |
Float | 5.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.52 |
PB Ratio | 0.66 |
P/TBV Ratio | 2.28 |
P/FCF Ratio | n/a |
P/OCF Ratio | 8.19 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -6.17 |
EV / Sales | 0.36 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.06.
Current Ratio | 1.48 |
Quick Ratio | 1.03 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -66.44 |
Financial Efficiency
Return on equity (ROE) is -7.15% and return on invested capital (ROIC) is -8.65%.
Return on Equity (ROE) | -7.15% |
Return on Assets (ROA) | -6.01% |
Return on Invested Capital (ROIC) | -8.65% |
Return on Capital Employed (ROCE) | -14.40% |
Revenue Per Employee | 610,553 |
Profits Per Employee | -35,605 |
Employee Count | 38 |
Asset Turnover | 0.82 |
Inventory Turnover | 2.66 |
Taxes
In the past 12 months, Medicure has paid 211,000 in taxes.
Income Tax | 211,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.86% in the last 52 weeks. The beta is 0.91, so Medicure's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +13.86% |
50-Day Moving Average | 1.17 |
200-Day Moving Average | 0.94 |
Relative Strength Index (RSI) | 56.08 |
Average Volume (20 Days) | 2,117 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 23.20 million and -1.35 million in losses. Loss per share was -0.13.
Revenue | 23.20M |
Gross Profit | 12.79M |
Operating Income | -2.72M |
Pretax Income | -1.14M |
Net Income | -1.35M |
EBITDA | -1.04M |
EBIT | -2.72M |
Loss Per Share | -0.13 |
Balance Sheet
The company has 4.74 million in cash and 1.09 million in debt, giving a net cash position of 3.65 million or 0.35 per share.
Cash & Cash Equivalents | 4.74M |
Total Debt | 1.09M |
Net Cash | 3.65M |
Net Cash Per Share | 0.35 |
Equity (Book Value) | 18.31M |
Book Value Per Share | 1.75 |
Working Capital | 4.59M |
Cash Flow
Operating Cash Flow | 1.47M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 55.14%, with operating and profit margins of -11.74% and -5.83%.
Gross Margin | 55.14% |
Operating Margin | -11.74% |
Pretax Margin | -4.92% |
Profit Margin | -5.83% |
EBITDA Margin | -4.47% |
EBIT Margin | -11.74% |
FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -11.27% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
Last Split Date | Nov 2, 2012 |
Split Type | Reverse |
Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -2.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.09 |
Piotroski F-Score | 3 |